Abstract
Bones are dynamic tissues with a great organization in structure not only a static support also with a great cellular and mineral capacity. The biology of bone fracture healing is a very complex process, through the understanding of the healing phases, is critical. Fracture healing can be divided into two main categories: primary bone healing and secondary bone healing although both healing responses can interact. Primary bone healing is similar to the bone remodeling which occurs under low interfragmentary movement or rigid fixation and under compression. Secondary bone healing is associated with motion on the fracture site, involves an inflammatory response and hematoma formation, repair phase (soft callus and hard callus), and remodeling. After a fracture blood vessels disruption, it leads to hematoma formation and the hematoma is intruded with immune cells; an inflammatory response elicits with pro-inflammatory cytokines IL-1, IL-6, TNF-α, and IFN-ϒ. The control of inflammatory response is critical for further process. After resolution of the inflammatory response, mesenchymal stem cells accumulate to the fracture side and differentiate into chondrocytes and osteoblasts. Further, with the controlled activity of macrophages, T- and B-lymphocytes, cytokines, and growth factors, soft callus is produced with endochondral formation followed by hard callus. Fracture healing is completed by the remodeling phase characterized by the balance between osteoblast and osteoclast functions under both systemic and local control pathways.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BMPs:
-
Bone morphogenetic proteins
- CXCL:
-
Chemokine motif ligand
- DMP1:
-
Dentin matrix protein
- ECM:
-
Extracellular matrix
- FGF-1:
-
Fibroblast growth factor-1
- GMCSF:
-
Granulocyte-macrophage colony-stimulating factor
- IFN-ϒ:
-
Interferon-ϒ
- IGF-1:
-
Insulin-like growth factor
- IL1-ra:
-
IL-1 receptor antagonist
- M-CSF:
-
Macrophage colony-stimulating factor
- MCP-1:
-
Monocyte chemotactic protein-1
- MEPE:
-
Matrix extracellular phospho-glycoprotein
- MIP-1 α:
-
Macrophage inflammatory protein-1 α
- MMPs:
-
Matrix metalloproteinases
- MSCs:
-
Mesenchymal stem cells
- NK cells:
-
Natural killer cells
- OPG:
-
Osteoprotegerin
- PBMCs:
-
Peripheral blood mononuclear cells
- PDGF:
-
Platelet-derived growth factor
- PMNs:
-
Polymorphonuclear neutrophils
- PTH:
-
Parathyroid hormone
- RANKL:
-
Receptor activator of nuclear factor kappa-B ligand
- SDF-1:
-
Stromal derived factor-1
- TGF-β:
-
Transforming growth factor beta
- TLRs:
-
Toll-like receptors
- TRAP:
-
Tartrate resistant acid phosphatase
- VEGF:
-
Vascular endothelial growth factor
References
Eriksen EF, Axelord D, Melsen F. Bone histomorphometry. New York: Raven Press; 1994.
Hennig C, Thomas CD, Clement JG, et al. Does 3D orientation account for variation in osteon morphology assessed by 2D histology? J Anat. 2015;227:497–505.
Augustin G, Antabak A, Davila S. The periosteum. Part 1: anatomy, histology and molecular biology. Injury. 2007;38:1115–30.
Roberts SJ, Van Gastel N, Carmeliet G, et al. Uncovering the periosteum for skeletal regeneration: the stem cell that lies beneath. Bone. 2015;70:10–8.
Jones DB, Nolte H, Scholubbers JG, et al. Biochemical signal transduction of mechanical strain in osteoblast-like cells. Biomaterials. 1991;12:101–10.
Midura RJ, Su X, Morcuende JA, et al. Parathyroid hormone rapidly stimulates hyaluronan synthesis by periosteal osteoblasts in the tibial diaphysis of the growing rat. J Biol Chem. 2003;278:51462–8.
Franz-Odendaal TA, Hall BK, Witten PE. Buried alive: how osteoblasts become osteocytes. Dev Dyn. 2006;235:176–90.
Rubin CT, Lanyon LE. Kappa Delta Award paper. Osteoregulatory nature of mechanical stimuli: function as a determinant for adaptive remodeling in bone. J Orthop Res. 1987;5:300–10.
Wysolmerski JJ. Osteocytic osteolysis: time for a second look? BoneKEy Rep. 2012;1:229.
Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337–42.
Dee RME, Hurst E. Principles of orthopaedic practice. New York: McGraw-Hill; 1988.
Blair HC, Teitelbaum SL, Ghiselli R, et al. Osteoclastic bone resorption by a polarized vacuolar proton pump. Science (New York, NY). 1989;245:855–7.
Florencio-Silva R, Sasso GR, Sasso-Cerri E, et al. Biology of bone tissue: structure, function, and factors that influence bone cells. Biomed Res Int. 2015;2015:421746.
Shea JE, Miller SC. Skeletal function and structure: implications for tissue-targeted therapeutics. Adv Drug Deliv Rev. 2005;57:945–57.
Clarke B. Normal bone anatomy and physiology. Clin J Am Soc Nephrol. 2008;3:S131–9.
Alford AI, Kozloff KM, Hankenson KD. Extracellular matrix networks in bone remodeling. Int J Biochem Cell Biol. 2015;65:20–31.
Dallas SL, Prideaux M, Bonewald LF. The osteocyte: an endocrine cell … and more. Endocr Rev. 2013;34:658–90.
Perren SM. Evolution of the internal fixation of long bone fractures. The scientific basis of biological internal fixation: choosing a new balance between stability and biology. J Bone Joint Surg. 2002;84:1093–110.
Thompson Z, Miclau T, Hu D, Helms JA. A model for intramembranous ossification during fracture healing. J Orthop Res. 2002;20:1091–8.
Shapiro F. Cortical bone repair. The relationship of the lacunar-canalicular system and intercellular gap junctions to the repair process. J Bone Joint Surg Am. 1988;70:1067–81.
Marsell R, Einhorn TA. The biology of fracture healing. Injury. 2011;42:551–5.
Delacure MD. Physiology of bone healing and bone grafts. Otolaryngol Clin North Am. 1994;27:859–74.
Bastian O, Pillay J, Alblas J, et al. Systemic inflammation and fracture healing. J Leukoc Biol. 2011;89:669–73.
Giannoudis PV, Einhorn TA, Marsh D. Fracture healing: the diamond concept. Injury. 2007;38(Suppl 4):S3–6.
El-Jawhari JJ, Jones E, Giannoudis PV. The roles of immune cells in bone healing; what we know, do not know and future perspectives. Injury. 2016;47:2399–406.
Cameron JA, Milner DJ, Lee JS, et al. Employing the biology of successful fracture repair to heal critical size bone defects. Curr Top Microbiol Immunol. 2013;367:113–32.
Segal AW. How superoxide production by neutrophil leukocytes kills microbes. Novartis Foundation symposium, Vol. 279; 2006. p. 92–8; discussion 98–100, 216–9.
Soehnlein O, Lindbom L, Weber C. Mechanisms underlying neutrophil-mediated monocyte recruitment. Blood. 2009;114:4613–23.
Timlin M, Toomey D, Condron C, et al. Fracture hematoma is a potent proinflammatory mediator of neutrophil function. J Trauma. 2005;58:1223–9.
Bozlar M, Aslan B, Kalaci A, et al. Effects of human granulocyte-colony stimulating factor on fracture healing in rats. Saudi Med J. 2005;26:1250–4.
Chan JK, Glass GE, Ersek A, et al. Low-dose TNF augments fracture healing in normal and osteoporotic bone by up-regulating the innate immune response. EMBO Mol Med. 2015;7:547–61.
Chung R, Cool JC, Scherer MA, et al. Roles of neutrophil-mediated inflammatory response in the bony repair of injured growth plate cartilage in young rats. J Leukoc Biol. 2006;80:1272–80.
Grogaard B, Gerdin B, Reikeras O. The polymorphonuclear leukocyte: has it a role in fracture healing? Arch Orthop Trauma Surg. 1990;109:268–71.
Kovtun A, Bergdolt S, Wiegner R, et al. The crucial role of neutrophil granulocytes in bone fracture healing. Eur Cell Mater. 2016;32:152–62.
Beuscher HU, Rausch UP, Otterness IG, et al. Transition from interleukin 1 beta (IL-1 beta) to IL-1 alpha production during maturation of inflammatory macrophages in vivo. J Exp Med. 1992;175:1793–7.
Sfeir C, Ho L, Doll BA, Azari K, Hollinger JO. Fracture repair. In: Lieberman JR, Friedlaender GE, editors. Bone regeneration and repair. Totowa: Humana Press; 2005. p. 21–44.
Kon T, Cho TJ, Aizawa T, et al. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res. 2001;16:1004–14.
Mountziaris PM, Mikos AG. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev. 2008;14:179–86.
Kitaura H, Zhou P, Kim H-J, et al. M-CSF mediates TNF-induced inflammatory osteolysis. J Clin Investig. 2005;115:3418–27.
Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001;104:487–501.
Lee SK, Lorenzo J. Cytokines regulating osteoclast formation and function. Curr Opin Rheumatol. 2006;18:411–8.
Gerstenfeld LC, Cullinane DM, Barnes GL, et al. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem. 2003;88:873–84.
Croitoru-Lamoury J, Lamoury FMJ, Caristo M, et al. Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO). PLoS One. 2011;6:e14698.
Dighe AS, Yang S, Madhu V, et al. Interferon gamma and T cells inhibit osteogenesis induced by allogeneic mesenchymal stromal cells. J Orthop Res. 2013;31:227–34.
Bocker W, Docheva D, Prall WC, et al. IKK-2 is required for TNF-alpha-induced invasion and proliferation of human mesenchymal stem cells. J Mol Med. 2008;86:1183–92.
Guiducci S, Manetti M, Romano E, et al. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro. Ann Rheum Dis. 2011;70:2011–21.
Ito H. Chemokines in mesenchymal stem cell therapy for bone repair: a novel concept of recruiting mesenchymal stem cells and the possible cell sources. Mod Rheumatol. 2011;21:113–21.
Kitaori T, Ito H, Schwarz EM, et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum. 2009;60:813–23.
Liu X, Duan B, Cheng Z, et al. SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion. Protein Cell. 2011;2:845–54.
Yellowley C. CXCL12/CXCR4 signaling and other recruitment and homing pathways in fracture repair. BoneKEy Rep. 2013;2:300.
Dimitriou R, Tsiridis E, Giannoudis PV. Current concepts of molecular aspects of bone healing. Injury. 2005;36:1392–404.
Dudakov JA, Hanash AM, Jenq RR, et al. Interleukin-22 drives endogenous thymic regeneration in mice. Science (New York, NY). 2012;336:91–5.
El-Zayadi AA, Jones E, Churchman SM, Baboolal TG, Cuthbert RJ, El-Jawhari JJ, Badawy AM, Alase AA, El-Sherbiny YM, Mcgonagle D. IL-22 drives the proliferation, migration and osteogenic differentiation of human bone marrow mesenchymal stem cells (MSCs): a novel cytokine that may contribute to aberrant new bone formation in human SpA. Arthritis Rheumatol. 2015;67(Suppl 10):263–8.
Han X, Yang Q, Lin L, et al. Interleukin-17 enhances immunosuppression by mesenchymal stem cells. Cell Death Differ. 2014;21:1758–68.
Krampera M. Mesenchymal stromal cell ‘licensing’: a multistep process. Leukemia. 2011;25:1408–14.
Nam D, Mau E, Wang Y, et al. T-lymphocytes enable osteoblast maturation via IL-17F during the early phase of fracture repair. PLoS One. 2012;7:e40044.
Sawa S, Lochner M, Satoh-Takayama N, et al. RORgammat+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol. 2011;12:320–6.
Scandella E, Bolinger B, Lattmann E, et al. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat Immunol. 2008;9:667–75.
Hoff P, Gaber T, Strehl C, et al. Immunological characterization of the early human fracture hematoma. Immunol Res. 2016;64:1195–206.
Cho TJ, Gerstenfeld LC, Einhorn TA. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res. 2002;17:513–20.
Stocum DL. Regenerative biology and medicine. Amsterdam: Elsevier; 2006.
Colnot C, Thompson Z, Miclau T, et al. Altered fracture repair in the absence of MMP9. Development. 2003;130:4123–33.
Huang WC, Sala-Newby GB, Susana A, et al. Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-kappaB. PLoS One. 2012;7:e42507.
Kosaki N, Takaishi H, Kamekura S, et al. Impaired bone fracture healing in matrix metalloproteinase-13 deficient mice. Biochem Biophys Res Commun. 2007;354:846–51.
Mcdonald MM, Morse A, Mikulec K, et al. Matrix metalloproteinase-driven endochondral fracture union proceeds independently of osteoclast activity. J Bone Miner Res. 2013;28:1550–60.
Gerstenfeld LC, Cho TJ, Kon T, et al. Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. J Bone Miner Res. 2003;18:1584–92.
Kondo M, Yamaoka K, Sonomoto K, et al. IL-17 inhibits chondrogenic differentiation of human mesenchymal stem cells. PLoS One. 2013;8:e79463.
Chen G, Deng C, Li YP. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci. 2012;8:272–88.
Nakase T, Yoshikawa H. Potential roles of bone morphogenetic proteins (BMPs) in skeletal repair and regeneration. J Bone Miner Metab. 2006;24:425–33.
Hanada R, Hanada T, Penninger JM. Physiology and pathophysiology of the RANKL/RANK system. Biol Chem. 2010;391:1365–70.
Udagawa N, Takahashi N, Yasuda H, et al. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology. 2000;141:3478–84.
Huang H, Kim HJ, Chang EJ, et al. IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ. 2009;16:1332–43.
Gilbert L, He X, Farmer P, et al. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology. 2000;141:3956–64.
Lam J, Takeshita S, Barker JE, et al. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest. 2000;106:1481–8.
Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop Relat Res. 1998;355:S7–21.
Ishida K, Matsumoto T, Sasaki K, et al. Bone regeneration properties of granulocyte colony-stimulating factor via neovascularization and osteogenesis. Tissue Eng Part A. 2010;16:3271–84.
Yang X, Ricciardi BF, Hernandez-Soria A, et al. Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone. 2007;41:928–36.
Takayanagi H, Ogasawara K, Hida S, et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature. 2000;408:600–5.
Croes M, Oner FC, Van Neerven D, et al. Proinflammatory T cells and IL-17 stimulate osteoblast differentiation. Bone. 2016;84:262–70.
Ono T, Okamoto K, Nakashima T, et al. IL-17-producing gammadelta T cells enhance bone regeneration. Nat Commun. 2016;7:10928.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 ISAKOS
About this chapter
Cite this chapter
Ercin, E., Hurmeydan, O.M., Karahan, M. (2017). Bone Anatomy and the Biologic Healing Process of a Fracture. In: Gobbi, A., Espregueira-Mendes, J., Lane, J., Karahan, M. (eds) Bio-orthopaedics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54181-4_34
Download citation
DOI: https://doi.org/10.1007/978-3-662-54181-4_34
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-54180-7
Online ISBN: 978-3-662-54181-4
eBook Packages: MedicineMedicine (R0)